901119-38-8Relevant articles and documents
METHOD OF BLOCKING OR AMELIORATING CYTOKINE RELEASE SYNDROME
-
Page/Page column 38-40, (2021/02/19)
Disclosed herein are embodiments of a method for treating or preventing cytokine release syndrome (CRS). In certain embodiments, the method comprises administering a compound, or a salt, solvate, prodrug or pharmaceutical composition thereof, to a subject experiencing, or at risk of developing, CRS. The compound may be a Syk inhibitor, and/or may have a structure according to Formula I. And the method may comprise administering the compound to a subject who is has received, is currently receiving, and/or will be receiving a cell therapy.
Synthesis of 2,4-Pyrimidinediamines
-
Page/Page column 10; 11, (2011/01/12)
Disclosed herein are methods for synthesizing 2,4-pyrimidinediamines as well as intermediates used therein.
PRODRUG SALTS OF 2, 4-PYRIMIDINEDIAMINE COMPOUNDS AND THEIR USES
-
Page/Page column 95-96, (2008/12/05)
The present disclosure provides prodrugs of biologically active 2,4- pyrimidinediamine compounds, salts and hydrates of the prodrugs, compositions. comprising the prodrugs, intermediates and methods for synthesizing the prodrugs and methods of using the prodrugs in a variety of applications. In particular the claims relate to salts of the phosphate ester of the following structure: